Literature DB >> 28516818

The changing epidemiology of spinal tuberculosis: the influence of international immigration in Catalonia, 1993-2014.

M Peghin1,2,3, D Rodriguez-Pardo1,2,3, A Sanchez-Montalva1,4, F Pellisé5, A Rivas6, T Tortola7, J Aguilar1, B Almirante1,2,3, C Pigrau1,2,3.   

Abstract

The overall incidence of spinal tuberculosis (TB) appears to be stable or declining in most European countries, but with an increasing proportion of cases in the foreign-born populations. We performed a retrospective observational study (1993-2014), including all cases of spinal TB diagnosed at a Barcelona hospital to assess the epidemiological changes. Fifty-four episodes (48·1% males, median age 52 years) of spinal TB were diagnosed. The percentage of foreign-born residents with spinal TB increased from 14% to 45·2% in the last 10 years (P = 0·017). Positive Mycobacterium tuberculosis testing in vertebral specimens was 88·2% (15/17) for GeneXpert MTB/RIF. Compared with natives, foreign-born patients were younger (P < 0·01) and required surgery more often (P = 0·003) because of higher percentages of paravertebral abscess (P = 0·038), cord compression (P = 0·05), and persistent neurological sequelae (P = 0·05). In our setting, one-third of spinal TB cases occurred in non-native residents. Compared with natives, foreign-born patients were younger and had greater severity of the disease. The GeneXpert MTB/RIF test may be of value for diagnosing spinal TB.

Entities:  

Keywords:  GeneXpert MTB/RIF; Pott disease; immigration; spinal tuberculosis; tuberculosis

Mesh:

Year:  2017        PMID: 28516818      PMCID: PMC9203422          DOI: 10.1017/S0950268817000863

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  23 in total

1.  The role of polymerase chain reaction in the management of osteoarticular tuberculosis.

Authors:  Vivek Pandey; Kiran Chawla; Kiran Acharya; Sripathi Rao; Sugandhi Rao
Journal:  Int Orthop       Date:  2007-11-24       Impact factor: 3.075

Review 2.  Vitamin D and tuberculosis: a review on a hot topic.

Authors:  Ludovica Facchini; Elisabetta Venturini; Luisa Galli; Maurizio de Martino; Elena Chiappini
Journal:  J Chemother       Date:  2015-06-09       Impact factor: 1.714

Review 3.  Musculoskeletal manifestations of human immunodeficiency virus infection.

Authors:  Ayaz A Biviji; Guy D Paiement; Lynne S Steinbach
Journal:  J Am Acad Orthop Surg       Date:  2002 Sep-Oct       Impact factor: 3.020

4.  Relating annual migration from high tuberculosis burden country of origin to changes in foreign-born tuberculosis notification rates in low-medium incidence European countries.

Authors:  Aidan Hanway; Catherine M Comiskey; Katy Tobin; Ronan F O'Toole
Journal:  Tuberculosis (Edinb)       Date:  2016-08-06       Impact factor: 3.131

5.  Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Authors:  David M Lewinsohn; Michael K Leonard; Philip A LoBue; David L Cohn; Charles L Daley; Ed Desmond; Joseph Keane; Deborah A Lewinsohn; Ann M Loeffler; Gerald H Mazurek; Richard J O'Brien; Madhukar Pai; Luca Richeldi; Max Salfinger; Thomas M Shinnick; Timothy R Sterling; David M Warshauer; Gail L Woods
Journal:  Clin Infect Dis       Date:  2017-01-15       Impact factor: 9.079

6.  Update on the treatment of tuberculosis and latent tuberculosis infection.

Authors:  Henry M Blumberg; Michael K Leonard; Robert M Jasmer
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

Review 7.  Spinal tuberculosis (Pott's disease): its clinical presentation, surgical management, and outcome. A survey study on 694 patients.

Authors:  M Turgut
Journal:  Neurosurg Rev       Date:  2001-03       Impact factor: 3.042

8.  Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates.

Authors:  Y Kong; M D Cave; L Zhang; B Foxman; C F Marrs; J H Bates; Z H Yang
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

9.  A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.

Authors:  Suran L Fernando; Bernadette M Saunders; Ronald Sluyter; Kristen K Skarratt; Hazel Goldberg; Guy B Marks; James S Wiley; Warwick J Britton
Journal:  Am J Respir Crit Care Med       Date:  2006-11-09       Impact factor: 21.405

Review 10.  Drug therapy in spinal tuberculosis.

Authors:  S Rajasekaran; Gaurav Khandelwal
Journal:  Eur Spine J       Date:  2012-05-12       Impact factor: 3.134

View more
  4 in total

1.  Comparison between single anterior and single posterior approaches of debridement interbody fusion and fixation for the treatment of mono-segment lumbar spine tuberculosis.

Authors:  Hangli Wu; Yaqing Cui; Liqun Gong; Jun Liu; Yayi Fan; Yongchun Zhou; Weiwei Li
Journal:  Arch Orthop Trauma Surg       Date:  2021-05-22       Impact factor: 3.067

2.  Monocyte-to-Lymphocyte Ratio Was an Independent Factor of the Severity of Spinal Tuberculosis.

Authors:  Liyi Chen; Chong Liu; Tuo Liang; Zhen Ye; Shengsheng Huang; Jiarui Chen; Xuhua Sun; Ming Yi; Jie Jiang; Tianyou Chen; Hao Li; Wuhua Chen; Hao Guo; Yuanlin Yao; Shian Liao; Chaojie Yu; Shaofeng Wu; Binguang Fan; Zhaoping Gan; Xinli Zhan
Journal:  Oxid Med Cell Longev       Date:  2022-05-20       Impact factor: 7.310

3.  Effects of migration on tuberculosis epidemiological indicators in low and medium tuberculosis incidence countries: A systematic review.

Authors:  Sarah Jackson; Zubair Kabir; Catherine Comiskey
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-02-22

4.  Candidate Biomarkers to Distinguish Spinal Tuberculosis From Mechanical Back Pain in a Tuberculosis Endemic Setting.

Authors:  Theresa N Mann; Johan H Davis; Gerhard Walzl; Caroline G Beltran; Jacques du Toit; Robert P Lamberts; Novel N Chegou
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.